New combo therapy aims to control blood cancer
Disease control
Completed
This study tested a 15-month treatment plan for adults newly diagnosed with chronic lymphocytic leukemia (CLL), a type of blood cancer. It combined three drugs: bendamustine and rituximab given first, followed by a year of the pill venetoclax. The goal was to see how well this se…
Phase: PHASE2 • Sponsor: Nicole Lamanna • Aim: Disease control
Last updated Mar 06, 2026 15:38 UTC